Skip to main content
padlock icon - secure page this page is secure

TCL1 expression predicts overall survival in patients with mantle cell lymphoma

Buy Article:

$59.00 + tax (Refund Policy)

Mantle cell lymphoma (MCL) has a heterogeneous clinical course. Although most cases show a poor prognosis, a minority has an indolent course. It is difficult to identify indolent MCL cases prospectively. T‐cell leukemia/lymphoma protein 1 (TCL1) is expressed by several B‐cell lymphomas, including MCL. This study examined the expression of TCL1 and its prognostic relevance for MCL.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: T‐cell leukemia/lymphoma protein 1; mantle cell lymphoma; mantle cell lymphoma international prognostic index; prognosis

Document Type: Research Article

Publication date: December 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more